Records containing: Systemic Mastocytosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-31Interest of Denosumab Treatment in Osteoporosis Associated to Systemic Mastocytosis
-
CLINICAL_TRIALS study record update · 2026-01-28A Phase 1 Trial to Evaluate the Safety of Single Agent Flotetuzumab in Advanced CD123-Positive Hematological Malignancies
-
CLINICAL_TRIALS study record update · 2025-08-26Mastocytosis From Pediatric Age to Adulthood: Local Registry of Cutaneous and Systemic Mastocytosis
-
CLINICAL_TRIALS study record update · 2022-11-10GTB-3550 (CD16/IL-15/CD33)Tri-Specific Killer Engager (TriKE®) for the Treatment of High Risk Myelodysplastic Syndromes, Refractory/Relapsed Acute Myeloid Leukemia and Advanced Systemic Mastocytosis
-
CLINICAL_TRIALS study record update · 2021-06-29A Phase IA/II Multicenter, Dose-escalation Study of Oral AMN107 on a Continuous Daily Dosing Schedule in Adult Patients With Imatinib-resistant/Intolerant CML in Chronic or Accelerated Phase or Blast Crisis, Relapsed/Refractory Ph+ ALL, and Other Hematologic Malignancies.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-12-17A Phase 2 Study to Evaluate the Anti-Tumor Activity of Single Agent Flotetuzumab in Advanced CD123-Positive Hematological Malignancies
-
CLINICAL_TRIALS study record update · 2020-04-10Treatment of Systemic Mastocytosis With Tamoxifen
-
CLINICAL_TRIALS study record update · 2019-07-15Evaluation of the Diagnostic Value of Level of Bone Marrow Tryptase in Adult Systemic Mastocytosis
-
CLINICAL_TRIALS study record update · 2019-01-29A Study of Brentuximab Vedotin (SGN-35) in CD30-Positive Systemic Mastocytosis With or Without an Associated Hematological Clonal Non-Mast Cell Lineage Disease (AHNMD)
-
CLINICAL_TRIALS study record update · 2018-09-20A Phase 2 Study of Ibrutinib in Advanced Systemic Mastocytosis
-
CLINICAL_TRIALS study record update · 2017-02-23Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes
-
CLINICAL_TRIALS study record update · 2016-09-29Randomized, Double-blind, Placebo-controlled, Crossover Design, Efficacy and Safety Study With PA101 in Patients With Indolent Systemic Mastocytosis
-
CLINICAL_TRIALS study record update · 2016-08-29Subcutaneous Cladribine Plus Pegylated Interpheron Alfa-2a in Advanced Systemic Mastocytosis With D816V and Other Exon 17 KIT Mutations.
-
CLINICAL_TRIALS study record update · 2016-08-29Imatinib Mesylate Therapy in Systemic Mastocytosis Patients Lacking KIT Mutations
-
CLINICAL_TRIALS study record update · 2012-02-08ONTAK (Denileukin Diftitox) in Patients With Systemic Mastocytosis
-
CLINICAL_TRIALS study record update · 2011-04-29Evaluation of RAD001 as Therapy for Patients With Systemic Mastocytosis
-
CLINICAL_TRIALS study record update · 2011-04-25Evaluation of Obatoclax Mesylate as Therapy for Patients With Systemic Mastocytosis
-
CLINICAL_TRIALS study record update · 2009-09-18Multicenter, Open-Label, Single Arm Phase II Clinical Trial of Dasatinib in the Treatment of Systemic Mastocytosis